Levodopa-dyskinesia incidence by age of Parkinson's disease onset

被引：0
|
作者：
Kumar, N
Van Gerpen, JA
Bower, JH
Ahlskog, JE
机构：
来源：
MOVEMENT DISORDERS | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P510
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [41] Ropinirole 24-hour prolonged release delays the onset of dyskinesia compared with carbidopa/levodopa in patients with Parkinson's disease treated with levodopa
    Watts, R. L.
    Sethi, K. D.
    Pahwa, R.
    Adams, B. E.
    Earl, N. L.
    MOVEMENT DISORDERS, 2007, 22 : S94 - S94
  • [42] A patient-centric disease framework for Parkinson's disease levodopa induced dyskinesia
    Shields, A. L.
    Mallya, U. G.
    Lane, R. M.
    Thomas, S. K.
    MOVEMENT DISORDERS, 2009, 24 : S68 - S68
  • [43] THE ASSOCIATION BETWEEN EARLY TREATMENT WITH AMANTADINE AND DELAYED ONSET OF LEVODOPA-INDUCED DYSKINESIA IN PATIENTS WITH PARKINSON'S DISEASE
    Wu, T. L.
    Wang, C. C.
    Lin, F. J.
    Wu, R. M.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E14 - E15
  • [44] BDNF val66met influences time to onset of levodopa-induced dyskinesia in Parkinson's disease
    Foltynie, T.
    Cheeran, B.
    Williams-Gray, C. H.
    Edwards, M. J.
    Schneider, S. A.
    Weinberger, D.
    Barker, R. A.
    Bhatia, K. P.
    MOVEMENT DISORDERS, 2008, 23 (01) : S326 - S327
  • [45] Electrophysiology marker of levodopa induced dyskinesia in Parkinson disease
    Hawong, H.
    Chung, K.
    Swann, N.
    MOVEMENT DISORDERS, 2022, 37 : S602 - S603
  • [46] The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia
    Zhang, Yu-han
    Tang, Bei-sha
    Song, Chen-yuan
    Xu, Qian
    Lou, Ming-xin
    Liu, Zhen-hua
    Yu, Ren-he
    Yan, Xin-xiang
    Guo, Ji-feng
    NEUROSCIENCE LETTERS, 2013, 556 : 109 - 112
  • [47] Clinical signs associated with levodopa-induced dyskinesia in Parkinson's disease
    Kipfer, S.
    Stephan, M. A.
    Schuepbach, M.
    Kaelin-Lang, A.
    MOVEMENT DISORDERS, 2009, 24 : S267 - S267
  • [48] Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease
    Nicoletti, Alessandra
    Mostile, Giovanni
    Nicoletti, Giuseppe
    Arabia, Gennarina
    Iliceto, Giovanni
    Lamberti, Paolo
    Marconi, Roberto
    Morgante, Letterio
    Barone, Paolo
    Quattrone, Aldo
    Zappia, Mario
    JOURNAL OF NEUROLOGY, 2016, 263 (05) : 888 - 894
  • [49] A Web Resource for Levodopa-Induced Dyskinesia Genetics in Parkinson's Disease
    Blankenburg, Hagen
    Falla, Marika
    Schwienbacher, Christine
    Fabbrini, Giovanni
    Berardelli, Alfredo
    Pramstaller, Peter P.
    Domingues, Francisco S.
    NEUROINFORMATICS, 2017, 15 (03) : 297 - 300
  • [50] Effect of Safinamide on Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
    Bhatt, Mohit
    Chirileanu, Dana
    Meshram, Chandrashekhar
    Stanzione, Paolo
    Forrest, Emma C.
    NEUROLOGY, 2010, 74 (09) : A319 - A319
12345